Kanak Pharma Private Limited

Kanak Pharma Private Limited - trading in Agra, Uttar Pradesh, India. FY 2026 financials & compliance.
CIN U85191UP2010PTC042852 Incorporated 16 December 2010 ROC Uttar Pradesh HQ Agra, Uttar Pradesh, India
Active Private Limited Company trading
Data last updated
Revenue · FY 2025
₹4.45 Cr
▼ 1% YoY
Net profit · FY 2025
₹74,965
Net margin 0.2%
EBITDA · FY 2025
₹3.01 Lakh
EBITDA margin 0.7%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Open charges
₹49 Lakh
Secured borrowings
Company age
16 yrs
Est. 2010
Directors on board
2
As per MCA filings

About Kanak Pharma Private Limited

Data last updated:

Kanak Pharma Private Limited is a private limited company based in Agra, Uttar Pradesh, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 16 December 2010 and has been in existence for over 16 years.

The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U85191UP2010PTC042852. Its GSTIN is 09AAECK2357H1ZG (Uttar Pradesh).

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Anoop Kumar Goyal and Yojna Goyal.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No. 3 Chandan Nagar Shahganj Bodla Road, Agra, Uttar Pradesh, India – 282010.

As per the financials filed for FY 2025, the company reported a revenue of ₹4.45 Cr, a decline of 1% compared to the previous year. For the same year it recorded a net profit of ₹74,965 (net margin 0.2%) and EBITDA of ₹3.01 Lakh (EBITDA margin 0.7%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 42% over five years.

As per MCA filings, the company has open charges of ₹49 Lakh on record. Court records list 4 cases involving the company, including 2 filed by the company and 2 filed against it; 3 cases are pending.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Kanak Pharma Private Limited
CIN U85191UP2010PTC042852
Registration Number 042852
Incorporation Date 16 December 2010
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    House No. 3 Chandan Nagar Shahganj Bodla Road, Agra, Uttar Pradesh, India – 282010
  • Industry
    Trading, Wholesale, Other Wholesale
Comprehensive company report
Kanak Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Kanak Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Kanak Pharma Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Kanak Pharma Private Limited

The main business activity of Kanak Pharma is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Kanak Pharma Private Limited

Kanak Pharma Private Limited is audited by V. THUKRAL & ASSOCIATES for the financial year 2017.

NameStatusAppointment DateCessation Date
V. THUKRAL & ASSOCIATESLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Kanak Pharma Private Limited

Kanak Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Anoop Kumar GoyalDirector16 Dec 201015 Years 9 MonthsCurrent
Yojna GoyalDirector16 Dec 201015 Years 9 MonthsCurrent

Financials of Kanak Pharma Private Limited FY 2025 filings available

Kanak Pharma Private Limited reported revenue of ₹4.45 Cr (down 1% YoY) for FY 2025.

Revenue · FY 2025
₹4.45 Cr ▼ 1%
Net profit · FY 2025
₹74,965 margin 0.2%
EBITDA · FY 2025
₹3.01 Lakh margin 0.7%

Compounded Annual Growth Rate (CAGR) of Kanak Pharma Private Limited

Revenue CAGR growth
1 year
▼ 1%
3 years · compounded
▼ 7%
5 years · compounded
▲ 42%
EBITDA CAGR growth
1 year
▲ 123%
3 years · compounded
▲ 3%
5 years · compounded
▲ 59%

Revenue fell 1% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 42%. EBITDA rose 123% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Kanak Pharma Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹3.01 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹74,965••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Kanak Pharma Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin0.7%••••••••••••••••
Net Profit Margin0.2%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Kanak Pharma are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Kanak Pharma Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Kanak Pharma Private Limited

Open charges
₹49 Lakh
Satisfied charges
None
Breakdown by lending institutions
Hdfc Bank Limited₹0.49 Cr
Latest charge details
DateLenderAmountStatus
27 Feb 2025Hdfc Bank Limited₹49 LakhOpen

Total charge records: 1 View all charges

Employees and EPFO Compliance at Kanak Pharma Private Limited

Employment history and EPFO contributions of people linked to Kanak Pharma.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Kanak Pharma Private Limited

Kanak Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
09AAECK2357H1ZGUttar PradeshActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Kanak Pharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Kanak Pharma Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Kanak Pharma Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Kanak Pharma Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Kanak Pharma Private Limited

Activity
30 Sep 2025
Kanak Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Kanak Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh Ii.
Charges
27 Feb 2025
A charge with Hdfc Bank Limited amounted to Rs. 49.00 Lakh with Charge ID 101148424 was registered on 27 Feb 2025.
Directors
16 Dec 2010
Anoop Kumar Goyal was appointed as a Director on 16 Dec 2010 & has been associated with this company since 15 years 9 months.
Directors
16 Dec 2010
Yojna Goyal was appointed as a Director on 16 Dec 2010 & has been associated with this company since 15 years 9 months.
Activity
16 Dec 2010
Kanak Pharma Private Limited was registered on 16 Dec 2010 with Roc Uttar Pradesh Ii & aged 15 years 9 months as per MCA records.

Frequently Asked Questions about Kanak Pharma Private Limited

Kanak Pharma is an active private limited company based in Agra, Uttar Pradesh, India. The company works in wholesale, within the trading industry. It was incorporated on 16 December 2010 (16+ years old) and is registered under CIN U85191UP2010PTC042852.

Kanak Pharma reported revenue of ₹4.45 Cr for FY 2025 (down 1% YoY).

Kanak Pharma has 2 current directors:

Kanak Pharma reported a net profit of ₹74,965 (net margin 0.2%) and EBITDA of ₹3.01 Lakh (EBITDA margin 0.7%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Kanak Pharma is -7% over three years and 42% over five years. In the latest year (FY 2025) revenue fell 1%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Kanak Pharma is 09AAECK2357H1ZG, registered in Uttar Pradesh.

The CIN (Corporate Identification Number) of Kanak Pharma is U85191UP2010PTC042852. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Kanak Pharma has 4 court cases on record: 2 filed by the company and 2 filed against it. 3 are pending. Most are in the high courts.

Kanak Pharma was incorporated on 16 December 2010, making it 16+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available